STEPHEN LEVINE: Open Payments
NPI 1659479038 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 45 payments from 13 companies in 2025. Trend: 2023 $987 · 2024 $998 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $174 |
| Otsuka America Pharmaceutical, Inc. | 6 | $154 |
| Alkermes, Inc. | 5 | $115 |
| E.R. Squibb & Sons, L.L.C. | 5 | $78 |
| Lundbeck LLC | 3 | $75 |
| ABBVIE INC. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Corium, LLC | 2 | $62 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
Products named: REXULTI, CAPLYTA, LYBALVI, COBENFY, VRAYLAR, HETLIOZ, Azstarys, Auvelity.
Industry payments across OH — which companies pay providers there.
